Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATX-101 Patient-Experience Management Study
NCT02007434Phase 3Completed
- Sponsor
- Kythera Biopharmaceuticals
- Start
- Dec 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sodium deoxycholate in submental fullness, sponsored by Kythera Biopharmaceuticals. Started Dec 2013; status: completed.
02
Drugs
sodium deoxycholate
03
Conditions
submental fullness
Beyond the preview
Go deeper on NCT02007434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02007434.